Immunology

Robust Response Mounted vs. Opportunistic Infection After Aggressive HIV Therapy

Published in AIDS Weekly, September 21st, 1998

University of California San Francisco (UCSF) researchers reported results that suggest the immune system of HIV patients mounts a robust response to at least one opportunistic infection following aggressive HIV drug therapy.

The finding, reported in the August 1998 issue of Nature Medicine, focused specifically on cytomegalovirus (CMV), the leading cause of blindness in people with AIDS. But the researchers said the study may help to clarify an ongoing question in HIV treatment: Do the CD4⁺ T cells that are replenished by the immune system after highly active antiretroviral therapy (HAART) create the pathogen-specific responses needed to combat the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1998-09-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry